Experimental intracerebral hematoma in the rat: Characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy

Ludmila Belayev, Andre Obenaus, Weizhao Zhao, Isabel Saul, Raul Busto, Chunyan Wu, Alexey Vigdorchik, Baowan Lin, Myron Ginsberg

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

We characterized acute intracerebral hemorrhage (ICH) in the rat by sequential magnetic resonance imaging (MRI) and correlated MRI findings with neurobehavior and histopathology. In addition, we investigated whether albumin treatment would reduce ICH-induced brain injury. ICH was produced in rats by a double-injection method in which 45 μl of fresh arterial blood was injected into the right striatum. Susceptibility-weighted (SWI) and T2-weighted (T2WI) MRI was carried out on a 4.7T magnet at 0-1 h, 6 h, 24 h, 72 h, and 7 days after ICH. Animals were treated with either 25% human albumin, 1.25 g/kg, or saline vehicle i.v. at 90 min after ICH. Neurological status was evaluated before ICH and after treatment (at 4 h, 24 h, 48 h, 72 h, and 7 days). Brains were then perfusion-fixed, re-imaged on an 11.7T magnet, and studied by histopathology and immunochemistry. MRI revealed a consistent hematoma involving the striatum and overlying corpus callosum, with significant volume changes over time. Lesion volumes computed from T2WI images and by histopathology agreed closely with one another and were highly correlated (p = 0.002). SWI lesion volumes were also highly correlated to histological volumes (p < 0.001) but overestimated histological hematoma volume by ∼ 5-fold. Albumin treatment significantly improved neurological scores compared to saline at 72 h (3.8 ± 0.6 vs. 1.5 ± 0.7) and 7 days (3.8 ± 0.4 vs. 1.3 ± 0.5, respectively, p < 0.05), but did not affect histological or MRI lesion volumes. Taken together, sequential MRI plus histopathology provides a comprehensive characterization of experimental ICH. Albumin treatment improves neurological deficit after ICH but does not affect MRI or histological hematoma size.

Original languageEnglish
Pages (from-to)146-155
Number of pages10
JournalBrain Research
Volume1157
Issue number1
DOIs
StatePublished - Jul 9 2007

Fingerprint

Cerebral Hemorrhage
Hematoma
Albumins
Magnetic Resonance Imaging
Magnets
Therapeutics
Immunochemistry
Corpus Callosum
Brain Injuries
Perfusion
Injections
Brain

Keywords

  • Albumin
  • Hematoma
  • Intracerebral hemorrhage
  • MRI
  • Neuroprotection
  • Rat

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Experimental intracerebral hematoma in the rat : Characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy. / Belayev, Ludmila; Obenaus, Andre; Zhao, Weizhao; Saul, Isabel; Busto, Raul; Wu, Chunyan; Vigdorchik, Alexey; Lin, Baowan; Ginsberg, Myron.

In: Brain Research, Vol. 1157, No. 1, 09.07.2007, p. 146-155.

Research output: Contribution to journalArticle

Belayev, Ludmila ; Obenaus, Andre ; Zhao, Weizhao ; Saul, Isabel ; Busto, Raul ; Wu, Chunyan ; Vigdorchik, Alexey ; Lin, Baowan ; Ginsberg, Myron. / Experimental intracerebral hematoma in the rat : Characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy. In: Brain Research. 2007 ; Vol. 1157, No. 1. pp. 146-155.
@article{f9ca65f8228f4817af0cbda3d967e864,
title = "Experimental intracerebral hematoma in the rat: Characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy",
abstract = "We characterized acute intracerebral hemorrhage (ICH) in the rat by sequential magnetic resonance imaging (MRI) and correlated MRI findings with neurobehavior and histopathology. In addition, we investigated whether albumin treatment would reduce ICH-induced brain injury. ICH was produced in rats by a double-injection method in which 45 μl of fresh arterial blood was injected into the right striatum. Susceptibility-weighted (SWI) and T2-weighted (T2WI) MRI was carried out on a 4.7T magnet at 0-1 h, 6 h, 24 h, 72 h, and 7 days after ICH. Animals were treated with either 25{\%} human albumin, 1.25 g/kg, or saline vehicle i.v. at 90 min after ICH. Neurological status was evaluated before ICH and after treatment (at 4 h, 24 h, 48 h, 72 h, and 7 days). Brains were then perfusion-fixed, re-imaged on an 11.7T magnet, and studied by histopathology and immunochemistry. MRI revealed a consistent hematoma involving the striatum and overlying corpus callosum, with significant volume changes over time. Lesion volumes computed from T2WI images and by histopathology agreed closely with one another and were highly correlated (p = 0.002). SWI lesion volumes were also highly correlated to histological volumes (p < 0.001) but overestimated histological hematoma volume by ∼ 5-fold. Albumin treatment significantly improved neurological scores compared to saline at 72 h (3.8 ± 0.6 vs. 1.5 ± 0.7) and 7 days (3.8 ± 0.4 vs. 1.3 ± 0.5, respectively, p < 0.05), but did not affect histological or MRI lesion volumes. Taken together, sequential MRI plus histopathology provides a comprehensive characterization of experimental ICH. Albumin treatment improves neurological deficit after ICH but does not affect MRI or histological hematoma size.",
keywords = "Albumin, Hematoma, Intracerebral hemorrhage, MRI, Neuroprotection, Rat",
author = "Ludmila Belayev and Andre Obenaus and Weizhao Zhao and Isabel Saul and Raul Busto and Chunyan Wu and Alexey Vigdorchik and Baowan Lin and Myron Ginsberg",
year = "2007",
month = "7",
day = "9",
doi = "10.1016/j.brainres.2007.04.077",
language = "English",
volume = "1157",
pages = "146--155",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Experimental intracerebral hematoma in the rat

T2 - Characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy

AU - Belayev, Ludmila

AU - Obenaus, Andre

AU - Zhao, Weizhao

AU - Saul, Isabel

AU - Busto, Raul

AU - Wu, Chunyan

AU - Vigdorchik, Alexey

AU - Lin, Baowan

AU - Ginsberg, Myron

PY - 2007/7/9

Y1 - 2007/7/9

N2 - We characterized acute intracerebral hemorrhage (ICH) in the rat by sequential magnetic resonance imaging (MRI) and correlated MRI findings with neurobehavior and histopathology. In addition, we investigated whether albumin treatment would reduce ICH-induced brain injury. ICH was produced in rats by a double-injection method in which 45 μl of fresh arterial blood was injected into the right striatum. Susceptibility-weighted (SWI) and T2-weighted (T2WI) MRI was carried out on a 4.7T magnet at 0-1 h, 6 h, 24 h, 72 h, and 7 days after ICH. Animals were treated with either 25% human albumin, 1.25 g/kg, or saline vehicle i.v. at 90 min after ICH. Neurological status was evaluated before ICH and after treatment (at 4 h, 24 h, 48 h, 72 h, and 7 days). Brains were then perfusion-fixed, re-imaged on an 11.7T magnet, and studied by histopathology and immunochemistry. MRI revealed a consistent hematoma involving the striatum and overlying corpus callosum, with significant volume changes over time. Lesion volumes computed from T2WI images and by histopathology agreed closely with one another and were highly correlated (p = 0.002). SWI lesion volumes were also highly correlated to histological volumes (p < 0.001) but overestimated histological hematoma volume by ∼ 5-fold. Albumin treatment significantly improved neurological scores compared to saline at 72 h (3.8 ± 0.6 vs. 1.5 ± 0.7) and 7 days (3.8 ± 0.4 vs. 1.3 ± 0.5, respectively, p < 0.05), but did not affect histological or MRI lesion volumes. Taken together, sequential MRI plus histopathology provides a comprehensive characterization of experimental ICH. Albumin treatment improves neurological deficit after ICH but does not affect MRI or histological hematoma size.

AB - We characterized acute intracerebral hemorrhage (ICH) in the rat by sequential magnetic resonance imaging (MRI) and correlated MRI findings with neurobehavior and histopathology. In addition, we investigated whether albumin treatment would reduce ICH-induced brain injury. ICH was produced in rats by a double-injection method in which 45 μl of fresh arterial blood was injected into the right striatum. Susceptibility-weighted (SWI) and T2-weighted (T2WI) MRI was carried out on a 4.7T magnet at 0-1 h, 6 h, 24 h, 72 h, and 7 days after ICH. Animals were treated with either 25% human albumin, 1.25 g/kg, or saline vehicle i.v. at 90 min after ICH. Neurological status was evaluated before ICH and after treatment (at 4 h, 24 h, 48 h, 72 h, and 7 days). Brains were then perfusion-fixed, re-imaged on an 11.7T magnet, and studied by histopathology and immunochemistry. MRI revealed a consistent hematoma involving the striatum and overlying corpus callosum, with significant volume changes over time. Lesion volumes computed from T2WI images and by histopathology agreed closely with one another and were highly correlated (p = 0.002). SWI lesion volumes were also highly correlated to histological volumes (p < 0.001) but overestimated histological hematoma volume by ∼ 5-fold. Albumin treatment significantly improved neurological scores compared to saline at 72 h (3.8 ± 0.6 vs. 1.5 ± 0.7) and 7 days (3.8 ± 0.4 vs. 1.3 ± 0.5, respectively, p < 0.05), but did not affect histological or MRI lesion volumes. Taken together, sequential MRI plus histopathology provides a comprehensive characterization of experimental ICH. Albumin treatment improves neurological deficit after ICH but does not affect MRI or histological hematoma size.

KW - Albumin

KW - Hematoma

KW - Intracerebral hemorrhage

KW - MRI

KW - Neuroprotection

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=34250657407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250657407&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2007.04.077

DO - 10.1016/j.brainres.2007.04.077

M3 - Article

C2 - 17543290

AN - SCOPUS:34250657407

VL - 1157

SP - 146

EP - 155

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -